Age-Related Macular Degeneration - part 10 ppsx

95. Stone EM, Fingert JH, Alward WLM, Nguyen TD, Polansky JR, Sunden SLF, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC. Identification of a gene that causes primary open angle glaucoma [see comments]. Sci- ence 1997;275(5300):668–670. 96. Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y, Hutchinson A, Dean M, Lupski JR, Leppert M. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration [see comments]. Science 1997;277 (5333):1805-1807. 97. Lewis RA, Lupski JR. Macular degeneration: the emerging genetics. Hosp Pract (Off Ed) 2000; 35(6):41-50,56–58. 98. Dryja TP, Briggs CE, Berson EL, Rosenfeld PJ, Abitbol M. ABCR gene and age-related mac- ular degeneration (Technical Comment). Science 1998;279:p1107. 99. Klaver CCW, Assink JJM, Bergen AAB, van Duijn CM. ABCR gene and macular degenera- tion (Technical Comment). Science 1998;279:1107. 100. Dean M, Allikmets R, Shroyer NF, Lupski JR, Lewis RA, Leppert M, Bernstein PS, Seddon JM. ABCR gene and age-related macular degeneration (Technical Comment). Science 1998;279:1107. 101. Stone EM, Webster AR, Vandenburgh K, LM Streb, Hockey RR, Lotery AJ, Sheffield VC. Allelic variation in ABCR associated with Stargardt disease but not age-related macular de- generation [letter]. Nat Genet 1998;20(4):328–329. 102. Kuroiwa S, Kojima H, Kikuchi T, Yoshimura N. ATP binding cassette transporter retina geno- types and age related macular degeneration: an analysis on exudative non-familial Japanese patients. Br J Ophthalmol 1999;83(5):613–615. 103. De La Paz MA, Guy VK, Abou-Donias, Heinis R, Brachen B, Vance JM, Gilbert JR, Gass JD. Haines JL, Pericak-Vance MA. Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. Ophthalmology 1999;106(8):1531–1536. 104. Fuse N, Suzuki T, Wada Y, Yoshida M, Shimura M, Abe T, Nakazawa M, Tamai M. Molec- ular genetic analysis of ABCR gene in Japanese dry form age-related macular degeneration. Jpn J Ophthalmol 2000;44(3):245–249. 105. Rivera A, White K, Stohr H, Steiner K, Hemmrich N, Grimm T, Jurklies B, Lorenz B, Scholl HP, Apfelstedt-Sylla E, Weber BH. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet 2000;67(4):800–813. 106. Guymer RH, Heon E, Lotery AJ, Munier FL, Schorderet DF, Baird PN, McNeil RJ, Haines H, Sheffield VC, Stone EM. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 2001;119(5):745–751. 107. Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 2000;67(2):487–491. 108. Allikmets R. Simple and complex ABCR: genetic predisposition to retinal disease. Am J Hum Genet 2000;67(4):793–799. 109. Long AD, Langley CH. The power of association studies to detect the contribution of candi- date genetic loci to variation in complex traits. Genome Res 1999; 9(8):720–731. 110. Allikmets R. Molecular genetics of age-related macular degeneration: current status. Eur J Ophthalmol 1999;9(4):255–265. 111. Lewis RA, Shroyer, Singh N, Allikmets R, Hutchinson A, Li Y, Jupski JR, Leppert M, Dean M. Genotype/phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet 1999;64(2):422–434. 112. Shroyer NF, Lewis RA, Allikmets R, Singh N, Dean M, Leppert M, Lupski JR. The rod pho- toreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from mono- genic to multifactorial. Vision Res 1999;39(15):2537–2544. Genetics of AMD 489 113. Simonelli F, Testa F, de Crechio GE, Rinaldi E, Hutchinson A, Atkinson A, Dean M, D’Urso, Allikmets R. New ABCR mutations and clinical phenotype in Italian patients with Stargardt diseas. Invest Ophthalmol Vis Sci 2000;41(3):892–897. 114. Souied EH, Ducroq D, Gerber S, Gherber I, Rozet JM, Perrault I, Munnich A, Dufier JL, Coscas G, Soubrane G, Kaplan J, Age-related macular degeneration in grandparents of pa- tients with Stargardt disease: genetic study. Am J Ophthalmol 1999;128(2):173–178. 115. Souied EH, Ducroq D, Rozet JM, Gerber S, Perrault I, Munnich A, Coscas G, Soubrane G, Kaplan J, ABCR gene analysis in familial exudative age–related macular degeneration. Invest Ophthalmol Vis Sci 2000;41(1):244–247. 116. Zhang K, Kniazeva M, Hutchinson A, Han M, Dean M, Allikmets R. The ABCR gene in re- cessive and dominant Stargardt diseases: a genetic pathway in macular degeneration [In Pro- cess Citation]. Genomics 1999;60(2):234–237. 117. Sun H, Nathans J. ABCR: rod photoreceptor-specific ABC transporter responsible for Star- gardt disease. Methods Enzymol 2000;315(4):879–897. 118. Sun H, Molday RS, Nathans J. Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease. J Biol Chem 1999;274(12):8269–8281. 119. Sun H, Smallwood PM, Nathans J. Biochemical defects in ABCR protein variants associated with human retinopathies. Nat Genet 2000;26(2):242–246. 120. Stone EM, Lotery AJ, Munier FL, Heon E, Piguet B, Guymer RH, Vandenburgh K, Cousin P, Nishimura O, Swiderski RE, Silvestri G, Mackey DA, Hageman GS, Bird AC, Sheffield VC, Schorderet DF. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 1999;22(2):199–202. 121. Souied EH. Ducroq D, Rozet JM, Gerber G, Perrault I, Munnich A, Coscas G, Soubrane G, Kaplan J. Analysis of the VMD2 and the EFEMP1 genes in familial cases of exudative age- related macular degeneration. Invest Ophthalmol Vis Sci 2001;42(4):S448. 122. Petrukhin K Koisti MJ, Bakall B, Li W, Xie G, Marknell T, Sandgren O, Forsman K, Holm- gren G, Andreasson S, Vujic M, Bergen AA, McGarty-Dugan V, Figueroa D, Austin CP, Met- zker ML, Caskey CT, Wadelius C. Identification of the gene responsible for Best macular dys- trophy. Nat Genet 1998;19(3):241–247. 123. Marquardt A, Stohr H, Passmore LA, Kramer F, Rivera A, Weber BH. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform mac- ular dystrophy (Best’s disease). Hum Mol Genet 1998;7(9):1517–1525. 124. Allikmets R, Seddon JM, Bernstein PS, Hutchinson A, Atkinson A, Sharma S, Gerrard B, W Li, Metzker ML, Wadelius C, Caskey CT, Dean M, Petrukhin K. Evaluation of the Best gene in patients with age-related macular degeneration and other maculopathies. Hum Genet 1999;104(6):449–453. 125. Kramer F, White K, Pauleikhoff D, Gehrig A, Passmore L, Rivera A, Rudolph G, Kellner U, Andrassi M, Lorenz B, Rohrschneider K, Blankenagel A, Jurklies B, Schilling H, Schutt F, Holz FG, Weber BH, Mutations in the VMD2 gene are associated with juvenile-onset vitelli- form macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age- related macular degeneration. Eur J Hum Genet 2000. 8(4):286–292. 126. Lotery AJ, Munier FL, Fishman GA, Weleber RG, Jacobson SG, Affatigato LM, Nichols BE, Schorderet DF, Sheffield VC, Stone, EM. Allelic variation in the VMD2 gene in Best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci 2000;41(6):1291–1296. 127. De La Paz MA, Pericak-Vance MA, Lennon F, Hanies JL, Seddon JM. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci 1997;38(6):1060–1065. 128. Felbor U, Doepner D, Schneider U, Zrenner E, Weber, BH. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies. Invest Ophthalmol Vis Sci 1997;38(6):1054–1059. 129. Shastry BS Trese, MT. Evaluation of the peripherin/RDS gene as a candidate gene in families with age-related macular degeneration. Ophthalmologica 1999;213(3):165–170. 490 Rosenfeld 130. Baird PN, Tomlin BM, McNeil RM. Weih LM, McCarty CA, Cain M, Guymer RM. Do sin- gle nucleotide polymorphisms (SNPs) in the peripherin/RDS gene play a role in AMD? Invest Ophthalmol Vis Sci 2001:42(4):S638. 131. Kakuk LE, Zhang, K Swaroop A,Yashar BM, Yang Z, Y Li, Petrunkhin K, Sieving PA, Ayya- gari R, Allikmets R. Analysis of the ELOVL4 gene in patients with AMD and dominant mac- ular dystrophies. Invest Ophthalmol Vis Sci 2001;42(4):S638. 132. Souied EH Benlian P, Amouyel P, Feingold J, Lagarde JP, Munnich A, Kaplan J, Coscas G, Soubrane, G. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998;125(3):353–359. 133. Klaver CC, Kliffen M, van Duijn CM, Hofman A, Cruts, M Grobbee DE, van Broeckhoven C, de Jong, PT. Genetic association of apolipoprotein E with age-related macular degenera- tion. Am J Hum Genet 1998;63(1):200–206. 134. Pang CP, Baum L, Chan WM, Lau TC, Poon PM, Lam DS. The apolipoprotein E epsilin4 al- lele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Oph- thalmologica 2000:214(4):289–291. 135. Schmidt S, Saunders AM, de La Paz MA, Postel EA, Heinis RM, Agarwal A, Scott WK, Gilbert JR, McDowell JG, Bazyk A, Gass JD, Haines JL, Pericak-Vance MA, Association of the Apolipoprotein E gene with age-related macular degeneration: possible effect modifica- tion by family history, age, and gender. Mol Vis 2000;6:287–293. 136. Klaver CCW, van Leeuwen R, van Duijn CM, Slooter A, Hofman A, de Jong PT. Apolipopro- tein E polymorphism and drusen, pigmentary changes, and late age-related maculopathy. The Rotterdam Study. Invest Ophthalmol Vis Sci 2001;42(4):S310. 137. Pericak-Vance MA, Schmidt S, Gorin MB, Haines JL, Ferrell R, Klaver CC, Postel EA, van Duijn CM, Saunders AM, Weeks DE. Association of the apolipoprotein E (APOE) gene with age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 2001;42(4):S311. 138. Klaver CC, Kliffen M, van Duijn CM, Hofman A, Cruts M, Grobbee DE, van Broeckhoven C, de Jong PT. Genetic association of apolipoprotein E with age-related macular degeneration [published erratum appears in Am J Hum Genet 1998;63(4):1252]. Am J Hum Genet 1998; 63(1):200–206. 139. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 2000;130(6):769–773. 140. Ohba N. Introduction to genetics in ophthalmology, value of family studies. Jpn J Ophthalmol 2000:44(3):320–321. 141. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986;93(5):552–558. 142. Kajiwara K, Berson EL, Dryja TP. Digenic retinitis pigmentosa due to mutations at the un- linked peripherin/RDS and ROM1 loci. Science 1994;264(5165):1604–1608. 143. Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco, Willett W. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111. 144. Sandberg MA, Weigel-DiFranco C, Rosner B, Berson, EL. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa. Invest Ophthalmol Vis Sci 1996;37(8):1693–1698. 145. Jacobson SG, Cideciyan AV, Regunath G, Rodriguez FJ, Vandenburgh K, Sheffield VC, Stone EM. Night blindness is Sorsby’s fundus dystrophy reversed by vitamin A. Nat Genet 1995:11(1):27–32. 146. Kaiser-Kupfer MI, Caruso RC, Valle D. Gyrate atrophy of the choroid and retina. Long-term reduction of ornithine slows retinal degeneration. Arch Ophthalmol 1991;109(11):1539–1548. 147. Runge P, Muller DP, McAllister J, Calver D, Lloyd JK, Taylor D. Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia. Br J Ophthalmol 1986;70(3):166–173. 148. Mata NL, Tzekov RT, Liu X, Weng J, Birch DG, Travis GH. Delayed dark adaptation and lipofusein accumulation in aber ϩ/Ϫ mica: implications for involvement of ABCR in age- related macular degeneration. Invest Ophthalmol 2001;42(8):1685–1690. Genetics of AMD 491 [...]... neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study Arch Ophthalmol 1999;117:1161–1173 9 Finger PT, Chakravarthy U, Augsburger JJ Radiotherapy and the treatment of age-related macular degeneration External beam radiation therapy is effective in the treatment of age-related macular degeneration Arch Ophthalmol 1998;116:1507–1511 10 Bergink GJ, Hoyng... macular degeneration Am J Ophthalmol 1988 ;105 :25–9 36 Roth DB, Downie AA, Charles ST Visual results after submacular surgery for neovascularization in age-related macular degeneration Opthalm Surg Lasers 1997;28:920–925 37 Merrill PT, LoRusso FJ, Lomeo MD, Saxe SJ, Khan MM, Lambert HM Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration Ophthalmology 1999 ;106 :782–789... photocoagulation of subfoveal neovascular lesions in age-related macular degeneration Results of a randomized clinical trial Arch Ophthalmol 1991 ;109 :1220–1231 6 Macular Photocoagulation Study Group Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration results of a randomized clinical trial Arch Ophthalmol 1991 ;109 :1232–1241 7 TAP Study Group Photodynamic therapy... Schachat AP, Hartranft CD Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 2000;130:419–428 16 Donahue SP, Wall M, Weingeist TA Interferon treatment of SRNV Ophthalmology 1994 ;101 :624–625 17 Fung WE Interferon alpha 2a for treatment of age-related macular degeneration Am J Ophthalmol 1991;112:349–350... TAP Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials— TAP report Treatment of age-related macular degeneration with photodynamic therapy Arch Ophthalmol 1999;117:1329–1345 8 Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zorafos L, Piguet... patients’ perceptions of quality of life associated with age-related macular degeneration Can J Ophthalmol 2000;35:127–133 7 Ware JE Jr, Sherbourne CD The MOS 36-item short-form health survey (SF-36), I Conceptual framework and item selection Med Care 1992;30:473–483 8 McHorney CA, Ware JE Jr, Raczek AE The MOS 36-item short-form health survey (SF-36), II: psychometric and clinical tests of validity in... The synthetic tetrapeptide RGDS (arginineglycine-aspartate-serine), which is derived from the cell-binding domain of fibronectin, decreases RPE binding to laminin-coated or fibronectin-coated dishes (66) When added simultaneously with the cells, binding of RPE to fibronectin-coated dishes and laminin-coated dishes can be blocked by an antibody to the ␤1-subunit of integrin but RPE cell binding to charged... membranes in age-related macular degeneration Br J Ophthalmol 1997;81:481–489 41 Pollack JS, Del Priore LV, Smith ME, Feiner MA, Kaplan HJ Postoperative abnormalities of the choriocapillaris in exudative age-related macular degeneration Br J Ophthalmol 1996;80:314–8 42 Akduman L, Desai V, Del Priore LV, Olk PJ, Kaplan HJ Perfusion of the subfoveal choriocapillaris affects visual recovery after submacular... description of the subscales of the SF-36 As a comprehensive QOL instrument, the SF-36 has often been used to complement vision-specific instruments, as discussed below (10 12) In these studies, correlations between the vision-specific instruments and the SF-36 subscales have usually been fairly low Table 1 Description of the Subscales of the Short-Form 36 (SF-36) SF-36 subscale Description Physical health... vision-related function in patients with age-related macular degeneration Ophthalmology In press The VF-14 was correlated with the SF-36 physical composite scale (PCS) but not with the mental composite scale (MCS) This may indicate that one limitation of the VF14 is that it does not assess the mental aspects of health-related QOL in patients with AMD Indeed, focus groups used to develop the NEI-VFQ . associated with age-related macular degeneration. Arch Ophthalmol 2001;119(5):745–751. 107 . Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. . (arginine- glycine-aspartate-serine), which is derived from the cell-binding domain of fibronectin, de- creases RPE binding to laminin-coated or fibronectin-coated dishes (66). When added si- multaneously. treatment of age-related mac- ular degeneration. External beam radiation therapy is effective in the treatment of age-related macular degeneration. Arch Ophthalmol 1998;116:1507–1511. 10. Bergink